Cosmos Health INC. (COSM) — SEC Filings

Overview

Cosmos Health INC. (COSM) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 14, 2025: Cosmos Health Inc. (COSM) reported a significant increase in revenue for the nine months ended September 30, 2025, reaching $45,568,655, up from $40,202,238 in the prior year, representing a 13.3% increase. Despite this revenue growth, the company's net loss widened to $8,999,055 for the nine-month

Sentiment Summary

Across 45 filings, the sentiment breakdown is: 7 bearish, 36 neutral, 2 mixed. The dominant filing sentiment for Cosmos Health INC. is neutral.

Filing Type Overview

Cosmos Health INC. (COSM) has filed 21 8-K, 5 10-Q, 2 DEF 14A, 7 S-1/A, 2 10-K, 2 S-1, 1 SC 13G/A, 1 DEFA14A, 3 8-K/A, 1 SC 13G with the SEC between Jan 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (45)

• 8-K Filing — 8-K · Dec 18, 2025
• 8-K Filing — 8-K · Nov 17, 2025
• Cosmos Health Revenue Jumps 13% Amid Widening Losses, Liquidity Boosted by $300M Note — 10-Q · Nov 14, 2025 Risk: high
  Cosmos Health Inc. (COSM) reported a significant increase in revenue for the nine months ended September 30, 2025, reaching $45,568,655, up from $40,202,238 in
• Cosmos Health Inc. Files 8-K with Key Disclosures — 8-K · Oct 17, 2025 Risk: low
  Cosmos Health Inc. filed an 8-K on October 17, 2025, reporting events as of October 15, 2025. The filing includes information related to Regulation FD Disclosur
• Cosmos Health Inc. Files 8-K on Officer Changes and Financials — 8-K · Oct 6, 2025 Risk: medium
  Cosmos Health Inc. filed an 8-K on October 6, 2025, reporting events as of September 30, 2025. The filing primarily concerns the departure of directors or certa
• Cosmos Health Inc. Files 8-K on Director/Officer Changes & More — 8-K · Oct 1, 2025 Risk: medium
  Cosmos Health Inc. filed an 8-K on October 1, 2025, reporting events as of September 30, 2025. The filing covers several items including the departure and elect
• Cosmos Health Files 8-K with Financials — 8-K · Sep 29, 2025 Risk: low
  Cosmos Health Inc. filed an 8-K on September 29, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, formerly know
• Cosmos Health Seeks Reverse Split, Massive Share Increase at Annual Meeting — DEF 14A · Aug 22, 2025 Risk: high
  Cosmos Health Inc. is holding its 2025 Annual Meeting of Stockholders on September 30, 2025, to address several critical proposals impacting its corporate struc
• Cosmos Health Inc. Files Q2 2025 10-Q with Key Transactions — 10-Q · Aug 18, 2025 Risk: medium
  Cosmos Health Inc. filed its 10-Q for the period ending June 30, 2025. The company, formerly known as Cosmos Holdings Inc., is involved in the wholesale of drug
• Cosmos Health Inc. Reports Material Agreement and Equity Sales — 8-K · Aug 11, 2025 Risk: medium
  Cosmos Health Inc. filed an 8-K on August 11, 2025, reporting on events that occurred on August 7, 2025. The filing indicates the company entered into a materia
• Cosmos Health Inc. Files 8-K on Agreements and Obligations — 8-K · Aug 6, 2025 Risk: medium
  Cosmos Health Inc. announced on August 5, 2025, the entry into a material definitive agreement and the creation of a direct financial obligation. The company al
• Cosmos Health Faces Steep Losses, Seeks $300M Capital Infusion — S-1/A · Jun 3, 2025 Risk: high
  Cosmos Health Inc. filed an S-1/A, revealing a significant net loss of $15.89 million for the three months ended March 31, 2025, compared to a net loss of $15.9
• Cosmos Health Inc. Files Q1 2025 10-Q — 10-Q · May 15, 2025 Risk: medium
  Cosmos Health Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Cosmos Holdings Inc., is incorporated in Nevada and opera
• Cosmos Health Faces Delisting Notice — 8-K · May 7, 2025 Risk: high
  Cosmos Health Inc. filed an 8-K on May 7, 2025, reporting a notice of delisting or failure to satisfy continued listing rules. The filing also includes financia
• Cosmos Health Files 2024 10-K — 10-K · Apr 15, 2025 Risk: medium
  Cosmos Health Inc. filed its 2024 10-K on April 15, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, previou
• Cosmos Health Inc. Files 8-K — 8-K · Feb 18, 2025 Risk: low
  Cosmos Health Inc. filed an 8-K on February 18, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain sp
• Cosmos Health Inc. Files S-1/A Amendment — S-1/A · Feb 7, 2025 Risk: medium
  Cosmos Health Inc. filed an S-1/A amendment on February 7, 2025, for its registration statement (No. 333-283910). The company, formerly known as Cosmos Holdings
• Cosmos Health Inc. Files 8-K on Financial Obligations — 8-K · Jan 29, 2025 Risk: medium
  Cosmos Health Inc. filed an 8-K on January 29, 2025, reporting a direct financial obligation or an obligation under an off-balance sheet arrangement as of Janua
• Cosmos Health Inc. Files 8-K with Material Agreements — 8-K · Jan 22, 2025 Risk: medium
  Cosmos Health Inc. filed an 8-K on January 22, 2025, reporting events as of December 31, 2024. The filing indicates the entry into a material definitive agreeme
• Cosmos Health Inc. Files S-1/A Update — S-1/A · Jan 14, 2025 Risk: medium
  Cosmos Health Inc. filed an S-1/A on January 14, 2025, to update its registration statement. The company, previously known as Cosmos Holdings Inc. and Prime Est
• Cosmos Health Files S-1/A for 300M Shares — S-1/A · Jan 10, 2025 Risk: high
  Cosmos Health Inc. filed an S-1/A on January 10, 2025, to register 300,000,000 shares of common stock. The company previously operated as Cosmos Holdings Inc. a
• Cosmos Health Files S-1/A for 300M Share Offering — S-1/A · Jan 6, 2025 Risk: medium
  Cosmos Health Inc. filed an S-1/A on January 6, 2025, to register 300,000,000 shares of common stock. The company, formerly known as Cosmos Holdings Inc., is in
• Cosmos Health Aims for $300M Stock Offering — S-1 · Dec 18, 2024 Risk: medium
  Cosmos Health Inc. filed an S-1 form on December 18, 2024, indicating a proposed offering of up to $300 million in common stock. The company, formerly known as
• Cosmos Health Inc. Files S-1/A Amendment — S-1/A · Dec 10, 2024 Risk: medium
  Cosmos Health Inc. filed an S-1/A amendment on December 10, 2024, related to its previous filing for the year ending December 31, 2023. The company, previously
• Cosmos Health Files S-1/A for 300M Share Offering — S-1/A · Nov 27, 2024 Risk: high
  Cosmos Health Inc. filed an S-1/A on November 27, 2024, detailing a proposed offering of 300,000,000 shares. The company reported revenue of $23,346,023 and a n
• Cosmos Health Inc. Files 8-K on Shareholder Votes — 8-K · Nov 21, 2024 Risk: low
  Cosmos Health Inc. filed an 8-K on November 21, 2024, reporting on matters submitted to a vote of security holders as of November 19, 2024. The filing details t
• SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Cosmos Health Q3 2024 10-Q Filed — 10-Q · Nov 14, 2024 Risk: medium
  Cosmos Health Inc. filed its Q3 2024 10-Q report on November 14, 2024, covering the period ending September 30, 2024. The company, formerly known as Cosmos Hold
• Cosmos Health Faces Delisting Concerns — 8-K · Nov 12, 2024 Risk: high
  Cosmos Health Inc. filed an 8-K on November 12, 2024, reporting a notice of delisting or failure to satisfy continued listing rules. The filing indicates potent
• Cosmos Health Inc. Files Proxy Materials — DEFA14A · Oct 29, 2024 Risk: low
  Cosmos Health Inc. filed a Definitive Additional Materials proxy statement on October 29, 2024. The filing relates to the company's proxy materials and indicate
• Cosmos Health Plans $100M Stock Offering — S-1 · Oct 28, 2024 Risk: high
  Cosmos Health Inc. filed an S-1 form on October 28, 2024, detailing a proposed offering of 300,000,000 shares of common stock. The company aims to raise up to $
• Cosmos Health Inc. Files Definitive Proxy Statement — DEF 14A · Oct 18, 2024 Risk: medium
  Cosmos Health Inc. filed a definitive proxy statement (DEF 14A) on October 18, 2024, for its fiscal year ending December 31, 2024. The filing provides informati
• Cosmos Health Inc. Files 8-K: Material Agreement & Equity Sales — 8-K · Sep 27, 2024 Risk: medium
  Cosmos Health Inc. entered into a material definitive agreement on September 26, 2024. The company also reported on unregistered sales of equity securities and
• Cosmos Health Files Q1 2024 10-Q — 10-Q · Aug 19, 2024 Risk: high
  Cosmos Health Inc. filed its 10-Q for the period ending March 31, 2024. The company reported a nominal share price of $0.001 and has a fiscal year end of Decemb
• Cosmos Health Files 2023 Annual Report — 10-K · Aug 5, 2024 Risk: medium
  Cosmos Health Inc. filed its 10-K for the fiscal year ending December 31, 2023. The company, formerly known as Cosmos Holdings Inc., is based in Thessaloniki, G
• Cosmos Health Files 8-K for Other Events — 8-K · Jul 22, 2024 Risk: medium
  Cosmos Health Inc. filed an 8-K on July 22, 2024, reporting an event that occurred on July 19, 2024. The filing pertains to "Other Events" and "Financial Statem
• Cosmos Health Inc. Amends 8-K Filing on Auditor Change — 8-K/A · May 28, 2024 Risk: medium
  Cosmos Health Inc. filed an amendment (8-K/A) on May 2, 2024, to its April 26, 2024, 8-K filing. This amendment addresses the dismissal of KPMG Certified Audito
• Cosmos Health Inc. Amends Accountant Dismissal Filing — 8-K/A · May 3, 2024 Risk: medium
  Cosmos Health Inc. filed an amendment (8-K/A) on May 3, 2024, to its April 26, 2024, Form 8-K. This amendment clarifies the dismissal of KPMG Certified Auditors
• Cosmos Health Inc. Amends Filing on Auditor Dismissal — 8-K/A · May 2, 2024 Risk: medium
  Cosmos Health Inc. filed an amendment (8-K/A) on May 2, 2024, to its April 26, 2024, Form 8-K. This amendment clarifies the dismissal of KPMG Certified Auditors
• Cosmos Health Changes Independent Auditors — 8-K · Apr 26, 2024 Risk: medium
  Cosmos Health Inc. filed an 8-K on April 26, 2024, to report a change in its certifying accountant. The company previously engaged Citrin Cooperman & Company, L
• Cosmos Health Inc. Enters Material Definitive Agreement — 8-K · Apr 25, 2024 Risk: medium
  Cosmos Health Inc. announced on April 19, 2024, that it entered into a material definitive agreement. The filing does not specify the other party involved in th
• Cosmos Health Faces Delisting Notice — 8-K · Apr 19, 2024 Risk: high
  Cosmos Health Inc. filed an 8-K on April 19, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing indica
• Cosmos Health Faces Delisting Concerns — 8-K · Mar 22, 2024 Risk: high
  Cosmos Health Inc. filed an 8-K on March 22, 2024, reporting a notice of delisting or failure to satisfy continued listing rules. The filing indicates potential
• SC 13G Filing — SC 13G · Feb 14, 2024
• Cosmos Health Files Routine 8-K on Jan 18 Event — 8-K · Jan 22, 2024
  Cosmos Health Inc. (COSM) filed an 8-K on January 22, 2024, reporting an event that occurred on January 18, 2024. This filing is a standard current report, indi

Risk Profile

Risk Assessment: Of COSM's 40 recent filings, 11 were flagged as high-risk, 24 as medium-risk, and 5 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Key financial metrics from Cosmos Health INC.'s most recent 10-Q filing (Nov 14, 2025):

• Revenue: $45,568,655
• Net Income: -$8,999,055
• EPS: N/A
• Debt-to-Equity: N/A
• Cash Position: $4,633,660
• Operating Margin: N/A
• Total Assets: N/A
• Total Debt: N/A

Key Executives

• United Arab Emirates
• Grigorios Siokas

Industry Context

The pharmaceutical and healthcare sectors are highly competitive and subject to stringent regulatory oversight. Companies often rely on product innovation, strategic partnerships, and efficient distribution to gain market share. Cosmos Health Inc. operates within this dynamic environment, focusing on expanding its product portfolio and distribution networks.

Top Tags

financials (8) · 8-K (5) · sec-filing (5) · amendment (5) · disclosure (4) · 10-Q (4) · material-agreement (4) · delisting (4) · auditor-change (4) · financial-obligation (3)

Key Numbers

• Revenue for nine months ended Sep 30, 2025: $45,568,655 — Increased from $40,202,238 in 2024, a 13.3% increase
• Net Loss for nine months ended Sep 30, 2025: $8,999,055 — Widened from $6,639,935 in 2024
• Net cash used in operating activities for nine months ended Sep 30, 2025: $3,851,273 — Indicates ongoing cash burn from operations
• Cash and restricted cash as of Sep 30, 2025: $4,633,660 — Significantly increased from $315,105 at Dec 31, 2024, due to financing activities
• Negative working capital as of Sep 30, 2025: $430,029 — Highlights short-term liquidity challenges
• Accumulated deficit as of Sep 30, 2025: $123,021,330 — Indicates significant historical losses
• Maximum value of senior secured convertible promissory notes: $300,000,000 — Potential future financing to support operations and growth
• Initial closing of convertible notes on August 6, 2025: $8,000,000 — Immediate liquidity injection
• Gross proceeds from ATM sales from Sep 22, 2025, to filing date: $4,376,622 — Further enhanced cash position and liquidity
• Shares of common stock issued via ATM sales: 3,992,541 — Indicates shareholder dilution
• Report Date: 20250930 — The date as of which the report's events are reported.
• Filing Date: 20251001 — The date the 8-K was officially filed with the SEC.
• Shares of Common Stock issued and outstanding: 30,127,379 — As of August 1, 2025 (Record Date)
• Proposed authorized shares of Common Stock: 1,500,000,000 — Significant increase from current levels, indicating potential for substantial future dilution
• Proposed authorized shares of 'blank check' Preferred Stock: 300,000,000 — New authorization for preferred stock, offering flexibility for future capital raises or strategic transactions

Frequently Asked Questions